Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Related structures:
AlphaFold database: Q4QEA5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 112 | 114 | PF00675 | 0.374 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.579 |
CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.477 |
CLV_PCSK_KEX2_1 | 104 | 106 | PF00082 | 0.337 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.559 |
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.570 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.542 |
CLV_PCSK_PC1ET2_1 | 38 | 40 | PF00082 | 0.570 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.542 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.677 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.491 |
DOC_USP7_UBL2_3 | 110 | 114 | PF12436 | 0.365 |
DOC_USP7_UBL2_3 | 25 | 29 | PF12436 | 0.695 |
DOC_USP7_UBL2_3 | 63 | 67 | PF12436 | 0.651 |
DOC_USP7_UBL2_3 | 90 | 94 | PF12436 | 0.517 |
DOC_WW_Pin1_4 | 24 | 29 | PF00397 | 0.601 |
LIG_14-3-3_CanoR_1 | 7 | 13 | PF00244 | 0.676 |
LIG_BRCT_BRCA1_1 | 74 | 78 | PF00533 | 0.581 |
LIG_FHA_2 | 57 | 63 | PF00498 | 0.561 |
LIG_LIR_Gen_1 | 75 | 82 | PF02991 | 0.593 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.618 |
LIG_SUMO_SIM_anti_2 | 11 | 16 | PF11976 | 0.675 |
MOD_CDK_SPK_2 | 24 | 29 | PF00069 | 0.601 |
MOD_CK2_1 | 56 | 62 | PF00069 | 0.557 |
MOD_Cter_Amidation | 23 | 26 | PF01082 | 0.662 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.523 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.565 |
MOD_NEK2_1 | 52 | 57 | PF00069 | 0.529 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.584 |
MOD_Plk_1 | 52 | 58 | PF00069 | 0.531 |
MOD_ProDKin_1 | 24 | 30 | PF00069 | 0.601 |
TRG_DiLeu_BaEn_4 | 53 | 59 | PF01217 | 0.604 |
TRG_ER_diArg_1 | 103 | 105 | PF00400 | 0.484 |
TRG_NLS_Bipartite_1 | 25 | 42 | PF00514 | 0.657 |
TRG_NLS_MonoExtC_3 | 112 | 117 | PF00514 | 0.511 |
TRG_NLS_MonoExtC_3 | 36 | 41 | PF00514 | 0.667 |
TRG_NLS_MonoExtN_4 | 110 | 117 | PF00514 | 0.476 |
TRG_NLS_MonoExtN_4 | 35 | 42 | PF00514 | 0.575 |
TRG_Pf-PMV_PEXEL_1 | 104 | 109 | PF00026 | 0.594 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KMF1 | Bodo saltans | 49% | 82% |
A0A1X0NKS3 | Trypanosomatidae | 56% | 98% |
A0A3Q8IAX0 | Leishmania donovani | 97% | 100% |
A4H949 | Leishmania braziliensis | 85% | 99% |
A4HXG3 | Leishmania infantum | 97% | 100% |
C9ZNE7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 59% | 92% |
E9AR58 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |